Signaling Pathways - Selective - Acute Myelogenous Leukemia - Kidney Injury Studies - Diabetes
清除全部
- B8016 UNC20251 CitationTarget: MER|FLT3Summary: 口服生物可利用的双重MER/FLT3抑制剂
- B5684 KL 001Target: CryptochromesSummary: 隐花色素蛋白(CRY)稳定剂
- B1483 Fenoldopam中文名: 非诺多泮Target: D1 and D5 ReceptorsSummary: D1样多巴胺受体部分激动剂
- B2283 Niclosamide中文名: 氯硝柳胺Target: STATSummary: STAT3信号通路抑制剂
- B2236 Desvenlafaxine中文名: 去甲文拉法辛Target: 5-HT Transporters|Norepinephrine transportersSummary: 5-羟色胺(5-HT)和去甲肾上腺素(NE)再摄取抑制剂
- B1879 AdipoRonTarget: AdipoR1|AdipoR2Summary: AdipoR1/2激动剂
- A8650 Saxagliptin中文名: 沙格列汀Target: DPP-4Summary: DPP4抑制剂
- A8403 CP-91149Target: Glycogen PhosphorylasesSummary: 糖原磷酸化酶选择性抑制剂
- A8395 CHIR-98014Target: GSK-3Summary: GSK-3β抑制剂
- A1663 PD980599 CitationTarget: MEKSummary: MEK抑制剂